Expanded Indication for 0.5mL Fluzone® Quadrivalent

The 0.5mL dose of Sanofi Pasteur’s Fluzone Quadrivalent vaccine has been newly approved to be used in children 6 months of age and older. This new option offers health care providers the simplicity of using the same 0.5mL dose for all eligible children when immunizing against the flu.  Fluzone Quadrivalent 0.25mL dose will still be available to order for children ages 6-35 months for the 2019-2020 season.

If you have already confirmed your 2019-2020 Sanofi Pasteur influenza vaccine reservation, you have the ability to adjust these quantities based on this new approval.

Contact your representative from Sanofi Pasteur or click here for more information.